Patents by Inventor Philip John Neale

Philip John Neale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
    Patent number: 6013245
    Abstract: The present invention relates to a pharmaceutical aerosol formulation which comprises particulate anhydrous beclomethasone dipropionate together with 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant, which formulation is free of surfactant. The formulation may also contain salbutamol and includes a canister suitable for delivery and a method of treating respiratory disorders administering the formulation by inhilation.
    Type: Grant
    Filed: August 24, 1998
    Date of Patent: January 11, 2000
    Assignee: Glaxo Group Limited
    Inventors: Anthony James Taylor, Philip John Neale
  • Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
    Patent number: 5833950
    Abstract: This invention relates to novel aerosol formulations for administering drugs, in particular, for the administration of a beclomethasone ester, by inhalation. In particular, the invention provides novel aerosol formulations consisting essentially of (a) beclomethasone dipropionate in the form of a solvate with 1,1,1,2-tetrafluoroethane (CF.sub.3 CH.sub.2 F) and one or more fluorocarbon or hydrogen-containing chlorofluorocarbon propellants, or (b) anhydrous beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant.
    Type: Grant
    Filed: June 18, 1997
    Date of Patent: November 10, 1998
    Assignee: Glaxo Group Limited
    Inventors: Anthony James Taylor, Philip John Neale
  • Medicaments
    Patent number: 5695744
    Abstract: This invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises: (a) beclomethasone dipropionate monohydrate, the particle size of substantially all the monohydrate being less than 20 microns; (b) at least 0.015% by weight of the formulation of water in addition to the water of crystallization associated with the monohydrate; and (c) a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.
    Type: Grant
    Filed: July 12, 1994
    Date of Patent: December 9, 1997
    Assignee: Glaxo Group Limited
    Inventors: Philip John Neale, Anthony James Taylor
  • Medicaments for treating respiratory disorders
    Patent number: 5688782
    Abstract: This invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises: (a) beclomethasone dipropionate monohydrate, the particle size of substantially all the monohydrate being less than 20 microns; (b) at least 0.015% by weight of the formulation of water in addition to the water of crystallization associated with the monohydrate; and (c) a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: November 18, 1997
    Assignee: Glaxo Group Limited
    Inventors: Philip John Neale, Anthony James Taylor